

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of synapse structural plasticity (GO:0051823) | 8.49445189 |
| 2 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 6.81886887 |
| 3 | angiotensin maturation (GO:0002003) | 5.86632530 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.69514330 |
| 5 | short-term memory (GO:0007614) | 5.61932111 |
| 6 | establishment of skin barrier (GO:0061436) | 5.36025612 |
| 7 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.26123848 |
| 8 | keratinization (GO:0031424) | 5.21835224 |
| 9 | synaptic vesicle maturation (GO:0016188) | 5.19114524 |
| 10 | behavioral response to ethanol (GO:0048149) | 5.11840559 |
| 11 | regulation of penile erection (GO:0060405) | 4.80496249 |
| 12 | regulation of guanylate cyclase activity (GO:0031282) | 4.76706757 |
| 13 | behavioral response to cocaine (GO:0048148) | 4.74959218 |
| 14 | glomerular filtration (GO:0003094) | 4.72402958 |
| 15 | regulation of water loss via skin (GO:0033561) | 4.69617747 |
| 16 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 4.56209846 |
| 17 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 4.56209846 |
| 18 | response to histamine (GO:0034776) | 4.52946916 |
| 19 | renal filtration (GO:0097205) | 4.37173457 |
| 20 | positive regulation of dendritic spine development (GO:0060999) | 4.26472343 |
| 21 | vocalization behavior (GO:0071625) | 4.26002345 |
| 22 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.21594223 |
| 23 | positive regulation of respiratory burst (GO:0060267) | 4.19924361 |
| 24 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 4.13398506 |
| 25 | chemosensory behavior (GO:0007635) | 4.06360634 |
| 26 | behavioral defense response (GO:0002209) | 4.00485191 |
| 27 | behavioral fear response (GO:0001662) | 4.00485191 |
| 28 | multicellular organismal water homeostasis (GO:0050891) | 3.94579467 |
| 29 | synaptic vesicle exocytosis (GO:0016079) | 3.94477951 |
| 30 | locomotory exploration behavior (GO:0035641) | 3.92890438 |
| 31 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.92704212 |
| 32 | positive regulation of protein export from nucleus (GO:0046827) | 3.90518124 |
| 33 | postsynaptic membrane organization (GO:0001941) | 3.85449795 |
| 34 | fear response (GO:0042596) | 3.85383337 |
| 35 | regulation of cellular extravasation (GO:0002691) | 3.81480070 |
| 36 | positive regulation of pseudopodium assembly (GO:0031274) | 3.78695233 |
| 37 | synaptic transmission, dopaminergic (GO:0001963) | 3.75172988 |
| 38 | neuron cell-cell adhesion (GO:0007158) | 3.71336358 |
| 39 | keratinocyte proliferation (GO:0043616) | 3.69551008 |
| 40 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.67250845 |
| 41 | regulation of dendritic spine development (GO:0060998) | 3.66787707 |
| 42 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.65256528 |
| 43 | intermediate filament organization (GO:0045109) | 3.64610267 |
| 44 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.63450533 |
| 45 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.63171699 |
| 46 | positive regulation of membrane potential (GO:0045838) | 3.62845658 |
| 47 | vitamin A metabolic process (GO:0006776) | 3.58786264 |
| 48 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.54483288 |
| 49 | regulation of pseudopodium assembly (GO:0031272) | 3.53637021 |
| 50 | intestinal absorption (GO:0050892) | 3.51605354 |
| 51 | positive regulation of neurotransmitter transport (GO:0051590) | 3.50817242 |
| 52 | hemidesmosome assembly (GO:0031581) | 3.50191979 |
| 53 | regulation of neurotransmitter uptake (GO:0051580) | 3.42745359 |
| 54 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.42551758 |
| 55 | water homeostasis (GO:0030104) | 3.42181420 |
| 56 | NADH metabolic process (GO:0006734) | 3.41128196 |
| 57 | renal system process involved in regulation of blood volume (GO:0001977) | 3.40303099 |
| 58 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.31167827 |
| 59 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.31167827 |
| 60 | complement activation, classical pathway (GO:0006958) | 3.29266967 |
| 61 | antimicrobial humoral response (GO:0019730) | 3.27052337 |
| 62 | membrane hyperpolarization (GO:0060081) | 3.26187237 |
| 63 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.23332080 |
| 64 | presynaptic membrane assembly (GO:0097105) | 3.20110459 |
| 65 | desmosome organization (GO:0002934) | 3.17155410 |
| 66 | regulation of norepinephrine secretion (GO:0014061) | 3.16313569 |
| 67 | regulation of cGMP biosynthetic process (GO:0030826) | 3.16024819 |
| 68 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.13014798 |
| 69 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.12031700 |
| 70 | antibacterial humoral response (GO:0019731) | 3.11830762 |
| 71 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.11591585 |
| 72 | hormone catabolic process (GO:0042447) | 3.10604820 |
| 73 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.09810165 |
| 74 | protein heterotrimerization (GO:0070208) | 3.07194088 |
| 75 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.05786925 |
| 76 | endocrine process (GO:0050886) | 3.05207748 |
| 77 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.05207748 |
| 78 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.05207748 |
| 79 | regulation of systemic arterial blood pressure (GO:0003073) | 3.02913751 |
| 80 | lipoprotein transport (GO:0042953) | 3.00758175 |
| 81 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.00678398 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.00092585 |
| 83 | keratinocyte differentiation (GO:0030216) | 2.99117131 |
| 84 | negative regulation of cyclase activity (GO:0031280) | 2.93241641 |
| 85 | cGMP-mediated signaling (GO:0019934) | 2.92260543 |
| 86 | adhesion of symbiont to host (GO:0044406) | 2.90976511 |
| 87 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.89675400 |
| 88 | sodium ion export (GO:0071436) | 2.87588333 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 2.87436814 |
| 90 | layer formation in cerebral cortex (GO:0021819) | 2.86260426 |
| 91 | collagen fibril organization (GO:0030199) | 2.85996845 |
| 92 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.84822676 |
| 93 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.83754095 |
| 94 | auditory receptor cell differentiation (GO:0042491) | 2.81108171 |
| 95 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.80685562 |
| 96 | trivalent inorganic anion homeostasis (GO:0072506) | 2.80420976 |
| 97 | phosphate ion homeostasis (GO:0055062) | 2.80420976 |
| 98 | cellular potassium ion homeostasis (GO:0030007) | 2.79925501 |
| 99 | negative regulation of lyase activity (GO:0051350) | 2.79683761 |
| 100 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.79317710 |
| 101 | glutathione biosynthetic process (GO:0006750) | 2.77614642 |
| 102 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.77567486 |
| 103 | complement activation (GO:0006956) | 2.77521261 |
| 104 | regulation of respiratory burst (GO:0060263) | 2.76435886 |
| 105 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.75628688 |
| 106 | neurotransmitter secretion (GO:0007269) | 2.74919246 |
| 107 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.72934062 |
| 108 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.71795272 |
| 109 | fructose metabolic process (GO:0006000) | 2.71151602 |
| 110 | epidermis development (GO:0008544) | 2.70593713 |
| 111 | dermatan sulfate biosynthetic process (GO:0030208) | 2.70263407 |
| 112 | regulation of keratinocyte proliferation (GO:0010837) | 2.69904748 |
| 113 | negative regulation of cation channel activity (GO:2001258) | 2.67758895 |
| 114 | virion attachment to host cell (GO:0019062) | 2.67125369 |
| 115 | adhesion of symbiont to host cell (GO:0044650) | 2.67125369 |
| 116 | cell communication by electrical coupling (GO:0010644) | 2.66382179 |
| 117 | regulation of cGMP metabolic process (GO:0030823) | 2.64635231 |
| 118 | keratan sulfate catabolic process (GO:0042340) | 2.63384300 |
| 119 | intermediate filament cytoskeleton organization (GO:0045104) | 2.62661793 |
| 120 | molting cycle (GO:0042303) | 2.62414361 |
| 121 | hair cycle (GO:0042633) | 2.62414361 |
| 122 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.61800518 |
| 123 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.61085120 |
| 124 | response to nitric oxide (GO:0071731) | 2.60000909 |
| 125 | positive regulation of synapse maturation (GO:0090129) | 2.59547606 |
| 126 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.58277630 |
| 127 | presynaptic membrane organization (GO:0097090) | 2.58169660 |
| 128 | alkaloid metabolic process (GO:0009820) | 2.58152283 |
| 129 | epidermal cell differentiation (GO:0009913) | 2.57970895 |
| 130 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.57770198 |
| 131 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.57676191 |
| 132 | exploration behavior (GO:0035640) | 2.56982926 |
| 133 | protein localization to synapse (GO:0035418) | 2.56841260 |
| 134 | intraspecies interaction between organisms (GO:0051703) | 2.56590202 |
| 135 | social behavior (GO:0035176) | 2.56590202 |
| 136 | negative regulation of catenin import into nucleus (GO:0035414) | 2.56061414 |
| 137 | negative regulation of microtubule polymerization (GO:0031115) | 2.55726125 |
| 138 | peptidyl-proline hydroxylation (GO:0019511) | 2.55084175 |
| 139 | peptide hormone processing (GO:0016486) | 2.53570988 |
| 140 | response to parathyroid hormone (GO:0071107) | 2.53396776 |
| 141 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.53395363 |
| 142 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.52968206 |
| 143 | intermediate filament-based process (GO:0045103) | 2.52921302 |
| 144 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.52050033 |
| 145 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.52021463 |
| 146 | regulation of synapse organization (GO:0050807) | 2.50896297 |
| 147 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.50833741 |
| 148 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.50813326 |
| 149 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.50181384 |
| 150 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.48892720 |
| 151 | regulation of postsynaptic membrane potential (GO:0060078) | 2.48748765 |
| 152 | membrane repolarization during action potential (GO:0086011) | 2.46674922 |
| 153 | cardiac conduction (GO:0061337) | 2.46391167 |
| 154 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.45391789 |
| 155 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.45292756 |
| 156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.44262456 |
| 157 | glycerol metabolic process (GO:0006071) | 2.44262090 |
| 158 | negative regulation of cAMP metabolic process (GO:0030815) | 2.43591197 |
| 159 | cellular response to nitric oxide (GO:0071732) | 2.43573558 |
| 160 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.43220773 |
| 161 | arachidonic acid secretion (GO:0050482) | 2.42981022 |
| 162 | icosanoid secretion (GO:0032309) | 2.42981022 |
| 163 | positive regulation of sodium ion transport (GO:0010765) | 2.42968296 |
| 164 | glutamate secretion (GO:0014047) | 2.41353908 |
| 165 | dermatan sulfate metabolic process (GO:0030205) | 2.40892821 |
| 166 | positive regulation of dendrite development (GO:1900006) | 2.40446798 |
| 167 | skin morphogenesis (GO:0043589) | 2.39237815 |
| 168 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.39201383 |
| 169 | retinol metabolic process (GO:0042572) | 2.39128914 |
| 170 | cGMP biosynthetic process (GO:0006182) | 2.38976983 |
| 171 | digestion (GO:0007586) | 2.38606600 |
| 172 | cell-cell junction maintenance (GO:0045217) | 2.37957557 |
| 173 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.37902867 |
| 174 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.37885908 |
| 175 | regulation of bile acid biosynthetic process (GO:0070857) | 2.37670557 |
| 176 | positive regulation of amine transport (GO:0051954) | 2.37445128 |
| 177 | drug metabolic process (GO:0017144) | 2.37023442 |
| 178 | gamma-aminobutyric acid transport (GO:0015812) | 2.36576987 |
| 179 | peptide cross-linking (GO:0018149) | 2.35731073 |
| 180 | membrane repolarization (GO:0086009) | 2.35450655 |
| 181 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.35371666 |
| 182 | lateral sprouting from an epithelium (GO:0060601) | 2.34567199 |
| 183 | negative regulation of cyclic nucleotide metabolic process (GO:0030800) | 2.34121894 |
| 184 | positive regulation of fatty acid oxidation (GO:0046321) | 2.33875859 |
| 185 | transcytosis (GO:0045056) | 2.33826763 |
| 186 | negative regulation of leukocyte migration (GO:0002686) | 2.33462257 |
| 187 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.32925666 |
| 188 | steroid hormone mediated signaling pathway (GO:0043401) | 2.32915246 |
| 189 | regulation of triglyceride catabolic process (GO:0010896) | 2.31885424 |
| 190 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.31144100 |
| 191 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.30954167 |
| 192 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.30954167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.48536443 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.59364622 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.48607106 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.16845681 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.85380665 |
| 6 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.83300303 |
| 7 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.80203359 |
| 8 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.76803409 |
| 9 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.73849613 |
| 10 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.73849613 |
| 11 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71911397 |
| 12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.61453821 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.56831325 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.41730987 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.40440602 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.33218933 |
| 17 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30760796 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.27463745 |
| 19 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21202330 |
| 20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.19694324 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.18135260 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.04187102 |
| 23 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.99030668 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96926765 |
| 25 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.92057371 |
| 26 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.83862280 |
| 27 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82182581 |
| 28 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.75852328 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68303947 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.64336645 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57215501 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52928746 |
| 33 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.52743859 |
| 34 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52233306 |
| 35 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49419694 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48433759 |
| 37 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.45835616 |
| 38 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45460243 |
| 39 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.42852185 |
| 40 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42001020 |
| 41 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40507103 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.36809860 |
| 43 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36751313 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.29709056 |
| 45 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25653315 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25625475 |
| 47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24039974 |
| 48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23299104 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23146981 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22479304 |
| 51 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.22435202 |
| 52 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20543157 |
| 53 | * CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20503803 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19689458 |
| 55 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19427663 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17322412 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.15448561 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14923032 |
| 59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14291694 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12451613 |
| 61 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10738372 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10170425 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09155719 |
| 64 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.08214401 |
| 65 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08083997 |
| 66 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07593886 |
| 67 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.07066270 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06001915 |
| 69 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05696755 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.05218858 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04281656 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04027305 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03092252 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03048107 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02898972 |
| 76 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.02779881 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02650921 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01849952 |
| 79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01771288 |
| 80 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.01657037 |
| 81 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01597464 |
| 82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00702371 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98752778 |
| 84 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97376821 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97304156 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95892406 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95613580 |
| 88 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95232751 |
| 89 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94372372 |
| 90 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.94248336 |
| 91 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.94235613 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93955348 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93952716 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93820280 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.93382442 |
| 96 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92971302 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92918732 |
| 98 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.92614949 |
| 99 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91125772 |
| 100 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.89957971 |
| 101 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.89926207 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89202953 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88139279 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86081710 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85988268 |
| 106 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.85587167 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.85554069 |
| 108 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.85133662 |
| 109 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84939993 |
| 110 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.83192003 |
| 111 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.82912156 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.82473570 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 0.80940206 |
| 114 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.79944338 |
| 115 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79620123 |
| 116 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.78580045 |
| 117 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78560590 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78560590 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78251475 |
| 120 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.78053335 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.77830345 |
| 122 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.77701145 |
| 123 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.77597222 |
| 124 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.77165792 |
| 125 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.77031621 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77008707 |
| 127 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76989136 |
| 128 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.76915443 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.76697150 |
| 130 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76533401 |
| 131 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76460744 |
| 132 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75978613 |
| 133 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.75669399 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.74820761 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.74688801 |
| 136 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74668918 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74477050 |
| 138 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.74445129 |
| 139 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.74260805 |
| 140 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.73980641 |
| 141 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.73786674 |
| 142 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.73404780 |
| 143 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.72871206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 5.55910037 |
| 2 | MP0005275_abnormal_skin_tensile | 5.29266153 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 5.18200939 |
| 4 | MP0005503_abnormal_tendon_morphology | 4.35951628 |
| 5 | MP0005360_urolithiasis | 4.17373557 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.76718818 |
| 7 | MP0003879_abnormal_hair_cell | 3.69555833 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 3.45069712 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 2.97681103 |
| 10 | MP0004858_abnormal_nervous_system | 2.81296363 |
| 11 | MP0009384_cardiac_valve_regurgitation | 2.71112295 |
| 12 | MP0005409_darkened_coat_color | 2.66385561 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.55608387 |
| 14 | MP0001958_emphysema | 2.53458631 |
| 15 | MP0001188_hyperpigmentation | 2.37340891 |
| 16 | MP0003279_aneurysm | 2.37027396 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.34166420 |
| 18 | MP0000751_myopathy | 2.17291449 |
| 19 | MP0009250_abnormal_appendicular_skeleto | 2.09568919 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 1.99804062 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.99529556 |
| 22 | MP0002909_abnormal_adrenal_gland | 1.98123143 |
| 23 | MP0003635_abnormal_synaptic_transmissio | 1.97333226 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.90291019 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.90092816 |
| 26 | MP0000566_synostosis | 1.81363380 |
| 27 | MP0002254_reproductive_system_inflammat | 1.72256772 |
| 28 | MP0002060_abnormal_skin_morphology | 1.69539632 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.63293001 |
| 30 | MP0004782_abnormal_surfactant_physiolog | 1.63104101 |
| 31 | MP0002796_impaired_skin_barrier | 1.62599741 |
| 32 | MP0009780_abnormal_chondrocyte_physiolo | 1.62136845 |
| 33 | MP0002063_abnormal_learning/memory/cond | 1.61342247 |
| 34 | MP0003329_amyloid_beta_deposits | 1.60742824 |
| 35 | MP0000678_abnormal_parathyroid_gland | 1.59149007 |
| 36 | MP0001664_abnormal_digestion | 1.59106002 |
| 37 | MP0004043_abnormal_pH_regulation | 1.58595945 |
| 38 | MP0000579_abnormal_nail_morphology | 1.57744237 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.56117956 |
| 40 | MP0009745_abnormal_behavioral_response | 1.55918433 |
| 41 | MP0004272_abnormal_basement_membrane | 1.55672385 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.52029706 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.51974502 |
| 44 | MP0001765_abnormal_ion_homeostasis | 1.43097722 |
| 45 | MP0000467_abnormal_esophagus_morphology | 1.43092252 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.40486703 |
| 47 | MP0005365_abnormal_bile_salt | 1.38668615 |
| 48 | MP0005595_abnormal_vascular_smooth | 1.37685417 |
| 49 | MP0002064_seizures | 1.36059454 |
| 50 | MP0003724_increased_susceptibility_to | 1.35907893 |
| 51 | MP0005670_abnormal_white_adipose | 1.33492838 |
| 52 | MP0003011_delayed_dark_adaptation | 1.30319253 |
| 53 | MP0002295_abnormal_pulmonary_circulatio | 1.29531296 |
| 54 | MP0005451_abnormal_body_composition | 1.29214292 |
| 55 | MP0002234_abnormal_pharynx_morphology | 1.29022165 |
| 56 | MP0000762_abnormal_tongue_morphology | 1.26390040 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.24842758 |
| 58 | MP0000750_abnormal_muscle_regeneration | 1.24634250 |
| 59 | MP0009053_abnormal_anal_canal | 1.24252864 |
| 60 | MP0002933_joint_inflammation | 1.23788752 |
| 61 | MP0003880_abnormal_central_pattern | 1.22269079 |
| 62 | MP0004270_analgesia | 1.20720405 |
| 63 | MP0003866_abnormal_defecation | 1.20648187 |
| 64 | MP0001243_abnormal_dermal_layer | 1.19158572 |
| 65 | MP0004147_increased_porphyrin_level | 1.17451344 |
| 66 | MP0010678_abnormal_skin_adnexa | 1.13929210 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.13797563 |
| 68 | MP0006054_spinal_hemorrhage | 1.13399379 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.12712634 |
| 70 | MP0005508_abnormal_skeleton_morphology | 1.11610984 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.11087995 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.10007300 |
| 73 | MP0004947_skin_inflammation | 1.07006063 |
| 74 | MP0010771_integument_phenotype | 1.06744353 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.06033943 |
| 76 | MP0005166_decreased_susceptibility_to | 1.05802339 |
| 77 | MP0001485_abnormal_pinna_reflex | 1.05267837 |
| 78 | MP0000647_abnormal_sebaceous_gland | 1.04604733 |
| 79 | MP0003868_abnormal_feces_composition | 1.03050643 |
| 80 | MP0002090_abnormal_vision | 1.01914720 |
| 81 | MP0000534_abnormal_ureter_morphology | 1.00580680 |
| 82 | MP0009643_abnormal_urine_homeostasis | 1.00410631 |
| 83 | MP0010030_abnormal_orbit_morphology | 0.98660004 |
| 84 | MP0005257_abnormal_intraocular_pressure | 0.98604855 |
| 85 | MP0000627_abnormal_mammary_gland | 0.97881650 |
| 86 | MP0001756_abnormal_urination | 0.96908789 |
| 87 | MP0003638_abnormal_response/metabolism_ | 0.95797743 |
| 88 | MP0001299_abnormal_eye_distance/ | 0.95690673 |
| 89 | MP0000383_abnormal_hair_follicle | 0.95411904 |
| 90 | MP0001542_abnormal_bone_strength | 0.95232578 |
| 91 | MP0001177_atelectasis | 0.94659469 |
| 92 | MP0001486_abnormal_startle_reflex | 0.92934684 |
| 93 | MP0000538_abnormal_urinary_bladder | 0.92893819 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.92472213 |
| 95 | MP0004381_abnormal_hair_follicle | 0.91576204 |
| 96 | MP0003385_abnormal_body_wall | 0.90553306 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.90506028 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.89675121 |
| 99 | MP0005332_abnormal_amino_acid | 0.87868436 |
| 100 | MP0008569_lethality_at_weaning | 0.87319231 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.86876008 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.86309098 |
| 103 | MP0000604_amyloidosis | 0.85513601 |
| 104 | MP0003941_abnormal_skin_development | 0.85483712 |
| 105 | MP0000427_abnormal_hair_cycle | 0.84880943 |
| 106 | MP0003075_altered_response_to | 0.84675533 |
| 107 | MP0000462_abnormal_digestive_system | 0.83891699 |
| 108 | MP0005501_abnormal_skin_physiology | 0.83106559 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.82618288 |
| 110 | MP0002115_abnormal_skeleton_extremities | 0.81108462 |
| 111 | MP0002971_abnormal_brown_adipose | 0.80636620 |
| 112 | MP0004036_abnormal_muscle_relaxation | 0.80434564 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.80333706 |
| 114 | MP0000465_gastrointestinal_hemorrhage | 0.79803841 |
| 115 | MP0008874_decreased_physiological_sensi | 0.77697329 |
| 116 | MP0002557_abnormal_social/conspecific_i | 0.77128482 |
| 117 | MP0002822_catalepsy | 0.76930006 |
| 118 | MP0005636_abnormal_mineral_homeostasis | 0.76445708 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.76388587 |
| 120 | MP0002249_abnormal_larynx_morphology | 0.75947715 |
| 121 | MP0009931_abnormal_skin_appearance | 0.75386993 |
| 122 | MP0001501_abnormal_sleep_pattern | 0.74683031 |
| 123 | MP0005023_abnormal_wound_healing | 0.73973584 |
| 124 | MP0002734_abnormal_mechanical_nocicepti | 0.73780125 |
| 125 | MP0000747_muscle_weakness | 0.73441004 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.73125428 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.72885667 |
| 128 | MP0001340_abnormal_eyelid_morphology | 0.72493273 |
| 129 | MP0000367_abnormal_coat/_hair | 0.71789274 |
| 130 | MP0000428_abnormal_craniofacial_morphol | 0.71334239 |
| 131 | MP0002272_abnormal_nervous_system | 0.70577284 |
| 132 | MP0009046_muscle_twitch | 0.70475111 |
| 133 | MP0004885_abnormal_endolymph | 0.70169574 |
| 134 | MP0005390_skeleton_phenotype | 0.69865183 |
| 135 | MP0002095_abnormal_skin_pigmentation | 0.69566188 |
| 136 | MP0005620_abnormal_muscle_contractility | 0.69383822 |
| 137 | MP0002837_dystrophic_cardiac_calcinosis | 0.69356404 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.68804999 |
| 139 | MP0005666_abnormal_adipose_tissue | 0.68275979 |
| 140 | MP0003283_abnormal_digestive_organ | 0.68232149 |
| 141 | MP0001881_abnormal_mammary_gland | 0.68193000 |
| 142 | MP0000049_abnormal_middle_ear | 0.68109379 |
| 143 | MP0000377_abnormal_hair_follicle | 0.66584469 |
| 144 | MP0001216_abnormal_epidermal_layer | 0.65879891 |
| 145 | MP0001663_abnormal_digestive_system | 0.65856496 |
| 146 | MP0004145_abnormal_muscle_electrophysio | 0.65814088 |
| 147 | MP0000163_abnormal_cartilage_morphology | 0.65705535 |
| 148 | MP0003755_abnormal_palate_morphology | 0.65618744 |
| 149 | MP0003122_maternal_imprinting | 0.64674213 |
| 150 | MP0004215_abnormal_myocardial_fiber | 0.64605460 |
| 151 | MP0001502_abnormal_circadian_rhythm | 0.64447156 |
| 152 | MP0005369_muscle_phenotype | 0.64230543 |
| 153 | MP0009840_abnormal_foam_cell | 0.64172045 |
| 154 | MP0001968_abnormal_touch/_nociception | 0.63956651 |
| 155 | MP0005448_abnormal_energy_balance | 0.63565978 |
| 156 | MP0004085_abnormal_heartbeat | 0.62762154 |
| 157 | MP0002098_abnormal_vibrissa_morphology | 0.62716538 |
| 158 | MP0001849_ear_inflammation | 0.62488757 |
| 159 | MP0005535_abnormal_body_temperature | 0.62400146 |
| 160 | MP0005076_abnormal_cell_differentiation | 0.62001020 |
| 161 | MP0000537_abnormal_urethra_morphology | 0.58852647 |
| 162 | MP0000681_abnormal_thyroid_gland | 0.57615192 |
| 163 | MP0005381_digestive/alimentary_phenotyp | 0.57255368 |
| 164 | MP0001879_abnormal_lymphatic_vessel | 0.56124234 |
| 165 | MP0000026_abnormal_inner_ear | 0.55740625 |
| 166 | MP0010368_abnormal_lymphatic_system | 0.54399289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 5.71947648 |
| 2 | Papilledema (HP:0001085) | 5.44519175 |
| 3 | Premature rupture of membranes (HP:0001788) | 5.41382781 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.05606747 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.76198402 |
| 6 | Palmoplantar hyperkeratosis (HP:0000972) | 4.72388568 |
| 7 | Abnormality of nail color (HP:0100643) | 4.46894718 |
| 8 | Atrophic scars (HP:0001075) | 4.41457396 |
| 9 | Palmar hyperkeratosis (HP:0010765) | 4.38221593 |
| 10 | Increased IgE level (HP:0003212) | 4.32993487 |
| 11 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.04794333 |
| 12 | Aplasia of the phalanges of the hand (HP:0009802) | 4.04794333 |
| 13 | Aplasia involving bones of the extremities (HP:0009825) | 4.04794333 |
| 14 | Tetraparesis (HP:0002273) | 4.00874343 |
| 15 | Malnutrition (HP:0004395) | 3.92438285 |
| 16 | Woolly hair (HP:0002224) | 3.79469778 |
| 17 | Shallow orbits (HP:0000586) | 3.67714421 |
| 18 | Abnormality of secondary sexual hair (HP:0009888) | 3.61320199 |
| 19 | Abnormality of the axillary hair (HP:0100134) | 3.61320199 |
| 20 | Conjunctival hamartoma (HP:0100780) | 3.58811099 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.55811011 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.55701531 |
| 23 | Erythroderma (HP:0001019) | 3.54091620 |
| 24 | Peritonitis (HP:0002586) | 3.53134977 |
| 25 | Decreased circulating renin level (HP:0003351) | 3.43797929 |
| 26 | Aortic dissection (HP:0002647) | 3.39176769 |
| 27 | Ankle contracture (HP:0006466) | 3.37576781 |
| 28 | Metabolic alkalosis (HP:0200114) | 3.36390074 |
| 29 | Pili torti (HP:0003777) | 3.30948486 |
| 30 | Hand muscle atrophy (HP:0009130) | 3.27618364 |
| 31 | Fragile skin (HP:0001030) | 3.20292869 |
| 32 | Hypophosphatemic rickets (HP:0004912) | 3.19821711 |
| 33 | Distal upper limb amyotrophy (HP:0007149) | 3.17471212 |
| 34 | Upper limb amyotrophy (HP:0009129) | 3.17471212 |
| 35 | Enlarged epiphyses (HP:0010580) | 3.15968055 |
| 36 | Thick nail (HP:0001805) | 3.07979680 |
| 37 | Tibial bowing (HP:0002982) | 3.06135847 |
| 38 | Distal lower limb amyotrophy (HP:0008944) | 3.02710039 |
| 39 | Fragile nails (HP:0001808) | 3.00907096 |
| 40 | Metaphyseal dysplasia (HP:0100255) | 3.00502635 |
| 41 | Round ear (HP:0100830) | 2.99104901 |
| 42 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.95350369 |
| 43 | Genu recurvatum (HP:0002816) | 2.92119084 |
| 44 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.91193631 |
| 45 | Bladder diverticulum (HP:0000015) | 2.89820276 |
| 46 | Abnormal hair laboratory examination (HP:0003328) | 2.86662845 |
| 47 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.86613906 |
| 48 | Soft skin (HP:0000977) | 2.85164713 |
| 49 | Fibular aplasia (HP:0002990) | 2.82839820 |
| 50 | Hyperactive renin-angiotensin system (HP:0000841) | 2.82331808 |
| 51 | Follicular hyperkeratosis (HP:0007502) | 2.81618088 |
| 52 | Erythema (HP:0010783) | 2.76392765 |
| 53 | Broad metatarsal (HP:0001783) | 2.73745224 |
| 54 | Hypophosphatemia (HP:0002148) | 2.71465083 |
| 55 | Abnormality of the vertebral endplates (HP:0005106) | 2.70846466 |
| 56 | Abnormality of renin-angiotensin system (HP:0000847) | 2.70628707 |
| 57 | Confusion (HP:0001289) | 2.69677903 |
| 58 | Focal motor seizures (HP:0011153) | 2.68853442 |
| 59 | Abnormality of dentin (HP:0010299) | 2.68184138 |
| 60 | Lower limb amyotrophy (HP:0007210) | 2.68078544 |
| 61 | Polyphagia (HP:0002591) | 2.68038604 |
| 62 | Osteomalacia (HP:0002749) | 2.67097711 |
| 63 | Upper limb muscle weakness (HP:0003484) | 2.65637584 |
| 64 | Dilatation of the ascending aorta (HP:0005111) | 2.61914790 |
| 65 | Action tremor (HP:0002345) | 2.57495618 |
| 66 | Synostosis involving the elbow (HP:0003938) | 2.57395111 |
| 67 | Humeroradial synostosis (HP:0003041) | 2.57395111 |
| 68 | Neonatal short-limb short stature (HP:0008921) | 2.56183357 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.52799753 |
| 70 | Long foot (HP:0001833) | 2.52639708 |
| 71 | Cerebral aneurysm (HP:0004944) | 2.45437835 |
| 72 | Deformed tarsal bones (HP:0008119) | 2.45169706 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.43679700 |
| 74 | Hyperextensible skin (HP:0000974) | 2.43248574 |
| 75 | Aortic aneurysm (HP:0004942) | 2.41543914 |
| 76 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.38853951 |
| 77 | Overgrowth (HP:0001548) | 2.38702416 |
| 78 | Loss of speech (HP:0002371) | 2.38050270 |
| 79 | Nemaline bodies (HP:0003798) | 2.35224740 |
| 80 | Genu varum (HP:0002970) | 2.34582990 |
| 81 | Abnormal blistering of the skin (HP:0008066) | 2.34500164 |
| 82 | Mitral valve prolapse (HP:0001634) | 2.34195641 |
| 83 | Corneal erosion (HP:0200020) | 2.31882967 |
| 84 | Hamartoma of the eye (HP:0010568) | 2.31507617 |
| 85 | Turricephaly (HP:0000262) | 2.31251630 |
| 86 | Ridged nail (HP:0001807) | 2.30068545 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.28574064 |
| 88 | Increased variability in muscle fiber diameter (HP:0003557) | 2.28204201 |
| 89 | Nonprogressive disorder (HP:0003680) | 2.27909451 |
| 90 | Hypotrichosis (HP:0001006) | 2.26152999 |
| 91 | Glomerulonephritis (HP:0000099) | 2.25857619 |
| 92 | Milia (HP:0001056) | 2.25403614 |
| 93 | Rickets (HP:0002748) | 2.24124146 |
| 94 | Femoral bowing (HP:0002980) | 2.23056009 |
| 95 | Alkalosis (HP:0001948) | 2.22801802 |
| 96 | Increased connective tissue (HP:0009025) | 2.22053320 |
| 97 | Exercise-induced myalgia (HP:0003738) | 2.21706991 |
| 98 | Acanthosis nigricans (HP:0000956) | 2.21354185 |
| 99 | Arterial tortuosity (HP:0005116) | 2.20165321 |
| 100 | Complement deficiency (HP:0004431) | 2.18645430 |
| 101 | Infantile muscular hypotonia (HP:0008947) | 2.17549731 |
| 102 | Chronic diarrhea (HP:0002028) | 2.17249446 |
| 103 | Muscle fiber inclusion bodies (HP:0100299) | 2.17141921 |
| 104 | Potter facies (HP:0002009) | 2.15967750 |
| 105 | Facial shape deformation (HP:0011334) | 2.15967750 |
| 106 | Abnormal eating behavior (HP:0100738) | 2.15431933 |
| 107 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.15289464 |
| 108 | Palmoplantar keratoderma (HP:0000982) | 2.14986527 |
| 109 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.14871585 |
| 110 | Mesomelia (HP:0003027) | 2.14381480 |
| 111 | Insidious onset (HP:0003587) | 2.12995886 |
| 112 | Termporal pattern (HP:0011008) | 2.12995886 |
| 113 | Vascular tortuosity (HP:0004948) | 2.09681666 |
| 114 | Ileus (HP:0002595) | 2.09393654 |
| 115 | Nail dystrophy (HP:0008404) | 2.07421290 |
| 116 | Striae distensae (HP:0001065) | 2.06832318 |
| 117 | Widely patent fontanelles and sutures (HP:0004492) | 2.06388018 |
| 118 | Epileptic encephalopathy (HP:0200134) | 2.06278293 |
| 119 | Abnormality of the 2nd finger (HP:0004100) | 2.04688531 |
| 120 | Irregular vertebral endplates (HP:0003301) | 2.03324789 |
| 121 | Increased density of long bones (HP:0006392) | 2.02965000 |
| 122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.01564382 |
| 123 | Hypoplasia of dental enamel (HP:0006297) | 2.01296082 |
| 124 | Short hallux (HP:0010109) | 2.00260716 |
| 125 | Narrow nasal bridge (HP:0000446) | 1.99990426 |
| 126 | Plantar hyperkeratosis (HP:0007556) | 1.99971701 |
| 127 | Abnormality of complement system (HP:0005339) | 1.99831080 |
| 128 | Slender build (HP:0001533) | 1.98997997 |
| 129 | Onycholysis (HP:0001806) | 1.98605092 |
| 130 | Achilles tendon contracture (HP:0001771) | 1.97457416 |
| 131 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.97355075 |
| 132 | Blue sclerae (HP:0000592) | 1.97348122 |
| 133 | Abnormality of vitamin B metabolism (HP:0004340) | 1.96758915 |
| 134 | Deviation of the hallux (HP:0010051) | 1.95961587 |
| 135 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.95937661 |
| 136 | Villous atrophy (HP:0011473) | 1.94332471 |
| 137 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.94332471 |
| 138 | Pigmentary retinal degeneration (HP:0001146) | 1.94305123 |
| 139 | Facial diplegia (HP:0001349) | 1.94170139 |
| 140 | Myokymia (HP:0002411) | 1.93535881 |
| 141 | Abnormality of permanent molar morphology (HP:0011071) | 1.93466672 |
| 142 | Abnormality of the dental root (HP:0006486) | 1.93466672 |
| 143 | Taurodontia (HP:0000679) | 1.93466672 |
| 144 | Wormian bones (HP:0002645) | 1.92925274 |
| 145 | Abnormal delivery (HP:0001787) | 1.92897785 |
| 146 | Spinal rigidity (HP:0003306) | 1.92570443 |
| 147 | Oral leukoplakia (HP:0002745) | 1.92193206 |
| 148 | Metaphyseal cupping (HP:0003021) | 1.91277639 |
| 149 | Abnormality of the musculature of the hand (HP:0001421) | 1.90808709 |
| 150 | Craniofacial hyperostosis (HP:0004493) | 1.90244891 |
| 151 | Hyperparathyroidism (HP:0000843) | 1.90115665 |
| 152 | Nephritis (HP:0000123) | 1.90015498 |
| 153 | Hydroxyprolinuria (HP:0003080) | 1.89152531 |
| 154 | Abnormality of proline metabolism (HP:0010907) | 1.89152531 |
| 155 | Persistence of primary teeth (HP:0006335) | 1.88533112 |
| 156 | Abnormality of molar morphology (HP:0011070) | 1.88055718 |
| 157 | Abnormality of molar (HP:0011077) | 1.88055718 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.87414041 |
| 159 | Glycosuria (HP:0003076) | 1.87414041 |
| 160 | Wide anterior fontanel (HP:0000260) | 1.85152632 |
| 161 | Ventricular fibrillation (HP:0001663) | 1.85025518 |
| 162 | Abnormal urine phosphate concentration (HP:0012599) | 1.84919159 |
| 163 | Hallux valgus (HP:0001822) | 1.84884030 |
| 164 | Right ventricular cardiomyopathy (HP:0011663) | 1.84664807 |
| 165 | Morphological abnormality of the middle ear (HP:0008609) | 1.84380499 |
| 166 | Bone cyst (HP:0012062) | 1.83960169 |
| 167 | Bronchomalacia (HP:0002780) | 1.82549017 |
| 168 | Absent eyelashes (HP:0000561) | 1.81953467 |
| 169 | Myotonia (HP:0002486) | 1.81918890 |
| 170 | Thin bony cortex (HP:0002753) | 1.81604757 |
| 171 | Abnormality of the Achilles tendon (HP:0005109) | 1.81309359 |
| 172 | Sudden death (HP:0001699) | 1.81301395 |
| 173 | Syncope (HP:0001279) | 1.79276453 |
| 174 | Focal seizures (HP:0007359) | 1.79114631 |
| 175 | Abnormality of Sharpey fibers (HP:0100685) | 1.78758631 |
| 176 | Bell-shaped thorax (HP:0001591) | 1.78653768 |
| 177 | Calcaneovalgus deformity (HP:0001848) | 1.77801627 |
| 178 | Biconcave vertebral bodies (HP:0004586) | 1.77226096 |
| 179 | Bowel diverticulosis (HP:0005222) | 1.76831814 |
| 180 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.75996542 |
| 181 | Alopecia of scalp (HP:0002293) | 1.75334503 |
| 182 | Tinnitus (HP:0000360) | 1.74633302 |
| 183 | Ectopia lentis (HP:0001083) | 1.72934582 |
| 184 | Exercise-induced muscle cramps (HP:0003710) | 1.71019506 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMKK2 | 8.07442173 |
| 2 | CAMK1D | 7.82679158 |
| 3 | CAMK1G | 6.03541403 |
| 4 | CAMKK1 | 4.01337150 |
| 5 | ACVR1B | 3.32322660 |
| 6 | MAP3K9 | 2.20601648 |
| 7 | PIK3CA | 2.04537778 |
| 8 | STK24 | 1.98024939 |
| 9 | PRKG2 | 1.88852791 |
| 10 | KSR2 | 1.82378380 |
| 11 | LATS2 | 1.63605898 |
| 12 | TNIK | 1.61366022 |
| 13 | OXSR1 | 1.59232812 |
| 14 | STK39 | 1.59208126 |
| 15 | LRRK2 | 1.55144928 |
| 16 | EPHA2 | 1.53291816 |
| 17 | EPHA4 | 1.52714472 |
| 18 | MAPK7 | 1.51572796 |
| 19 | NTRK3 | 1.49389392 |
| 20 | MYLK | 1.46594907 |
| 21 | CAMK1 | 1.40578333 |
| 22 | DDR2 | 1.38348518 |
| 23 | TAOK1 | 1.37430709 |
| 24 | PHKG1 | 1.37216852 |
| 25 | PHKG2 | 1.37216852 |
| 26 | LIMK1 | 1.35943938 |
| 27 | TRIB3 | 1.35650551 |
| 28 | CAMK4 | 1.34591952 |
| 29 | KSR1 | 1.33901319 |
| 30 | MAPKAPK3 | 1.30843076 |
| 31 | TTN | 1.24061572 |
| 32 | GRK1 | 1.22595871 |
| 33 | RIPK4 | 1.19672334 |
| 34 | TGFBR1 | 1.18889500 |
| 35 | MAP3K13 | 1.18842804 |
| 36 | MAP3K12 | 1.15359773 |
| 37 | PAK6 | 1.14812730 |
| 38 | ARAF | 1.14435530 |
| 39 | NLK | 1.13852647 |
| 40 | WNK4 | 1.13778958 |
| 41 | NTRK2 | 1.12149121 |
| 42 | NTRK1 | 1.09622031 |
| 43 | PDGFRA | 1.08694999 |
| 44 | ERBB2 | 1.07277625 |
| 45 | SGK494 | 1.06631127 |
| 46 | SGK223 | 1.06631127 |
| 47 | SIK1 | 1.05817688 |
| 48 | EPHB1 | 1.03696520 |
| 49 | TLK1 | 1.01854112 |
| 50 | MAPKAPK5 | 1.01485252 |
| 51 | FGFR3 | 1.00976881 |
| 52 | ERN1 | 1.00515614 |
| 53 | FGFR4 | 0.98948335 |
| 54 | TGFBR2 | 0.98529629 |
| 55 | PINK1 | 0.97183783 |
| 56 | EPHB2 | 0.90192533 |
| 57 | ADRBK1 | 0.88600730 |
| 58 | PRKD3 | 0.88398455 |
| 59 | PAK3 | 0.86473713 |
| 60 | RPS6KA2 | 0.85898612 |
| 61 | MAP3K6 | 0.77713607 |
| 62 | SGK2 | 0.77499378 |
| 63 | MAP2K2 | 0.76918321 |
| 64 | FER | 0.76290674 |
| 65 | MAP3K11 | 0.74844014 |
| 66 | KIT | 0.72616667 |
| 67 | LMTK2 | 0.72582206 |
| 68 | JAK1 | 0.71495081 |
| 69 | MATK | 0.71153408 |
| 70 | DAPK2 | 0.70456905 |
| 71 | ADRBK2 | 0.69550662 |
| 72 | TIE1 | 0.68320200 |
| 73 | PRKAA2 | 0.67673893 |
| 74 | MAPK4 | 0.63848298 |
| 75 | ABL2 | 0.63178919 |
| 76 | GRK6 | 0.62159387 |
| 77 | PRKACG | 0.61567784 |
| 78 | SGK1 | 0.61534745 |
| 79 | SIK2 | 0.61195784 |
| 80 | MINK1 | 0.60410895 |
| 81 | MAP3K7 | 0.59807744 |
| 82 | MAP3K10 | 0.59349746 |
| 83 | NME1 | 0.58188137 |
| 84 | PRKCA | 0.55776270 |
| 85 | PRKCZ | 0.55232312 |
| 86 | MOS | 0.55107633 |
| 87 | RAF1 | 0.54222839 |
| 88 | RIPK1 | 0.53871723 |
| 89 | OBSCN | 0.53780238 |
| 90 | MAP2K1 | 0.53287790 |
| 91 | CDK5 | 0.52781944 |
| 92 | PRKD2 | 0.52751873 |
| 93 | MAP2K6 | 0.52718070 |
| 94 | MAP3K2 | 0.52187891 |
| 95 | IGF1R | 0.51653202 |
| 96 | ICK | 0.49511598 |
| 97 | PDK3 | 0.48563763 |
| 98 | PDK4 | 0.48563763 |
| 99 | PKN2 | 0.47934772 |
| 100 | PRKACA | 0.47793007 |
| 101 | PDPK1 | 0.47469632 |
| 102 | PRKCH | 0.47246433 |
| 103 | SGK3 | 0.45799466 |
| 104 | PLK2 | 0.45614887 |
| 105 | HIPK2 | 0.43249187 |
| 106 | CASK | 0.43068540 |
| 107 | GRK5 | 0.42903068 |
| 108 | WNK1 | 0.41285729 |
| 109 | CDK19 | 0.41246678 |
| 110 | PTK2B | 0.41171390 |
| 111 | CAMK2D | 0.40887990 |
| 112 | TYK2 | 0.39936772 |
| 113 | MAP3K1 | 0.39776188 |
| 114 | FGFR2 | 0.39498091 |
| 115 | BMX | 0.39353889 |
| 116 | MST1R | 0.38438889 |
| 117 | MARK1 | 0.38114291 |
| 118 | PRKCG | 0.37790574 |
| 119 | CSNK1A1 | 0.37376945 |
| 120 | PDK2 | 0.37279217 |
| 121 | TESK1 | 0.35155072 |
| 122 | CDC42BPA | 0.34909339 |
| 123 | STK38 | 0.33736323 |
| 124 | MAP2K4 | 0.31214658 |
| 125 | PRKCE | 0.29469335 |
| 126 | CDK15 | 0.29253058 |
| 127 | LATS1 | 0.29117422 |
| 128 | EPHA3 | 0.28873648 |
| 129 | TAOK3 | 0.28433816 |
| 130 | UHMK1 | 0.28001560 |
| 131 | FES | 0.27378624 |
| 132 | MET | 0.27366778 |
| 133 | STK11 | 0.27324581 |
| 134 | FYN | 0.27298736 |
| 135 | TYRO3 | 0.26534416 |
| 136 | ROCK2 | 0.25838893 |
| 137 | CDK18 | 0.25774336 |
| 138 | CDK14 | 0.25639623 |
| 139 | CAMK2A | 0.24197138 |
| 140 | PTK2 | 0.24018108 |
| 141 | CDK11A | 0.23765773 |
| 142 | CAMK2G | 0.23663800 |
| 143 | PIK3CG | 0.23447005 |
| 144 | PTK6 | 0.23441102 |
| 145 | PDGFRB | 0.23389836 |
| 146 | MAPK12 | 0.23327543 |
| 147 | BMPR2 | 0.22328581 |
| 148 | FGR | 0.21343246 |
| 149 | SRC | 0.20852574 |
| 150 | RET | 0.20833171 |
| 151 | TBK1 | 0.19836817 |
| 152 | PDK1 | 0.19157978 |
| 153 | ROCK1 | 0.18875005 |
| 154 | CAMK2B | 0.18322682 |
| 155 | DMPK | 0.17624507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.25183017 |
| 2 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.09953932 |
| 3 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.80567191 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.67989563 |
| 5 | Histidine metabolism_Homo sapiens_hsa00340 | 2.47556571 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.35419097 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.30590821 |
| 8 | Mineral absorption_Homo sapiens_hsa04978 | 2.18344433 |
| 9 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.07281693 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.07117991 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.90859142 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88163516 |
| 13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.87812993 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.84488467 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.79373118 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77618200 |
| 17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.76513172 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.68460163 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.67265785 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.66781077 |
| 21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.66143693 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65226376 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64200494 |
| 24 | Retinol metabolism_Homo sapiens_hsa00830 | 1.59562644 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58890392 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.57024428 |
| 27 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.56657056 |
| 28 | Long-term potentiation_Homo sapiens_hsa04720 | 1.56251230 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55359424 |
| 30 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.55230225 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.50924952 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49728810 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.48331636 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47952643 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47613431 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.46124947 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.44932425 |
| 38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.44189850 |
| 39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.42252068 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.40234173 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.40001403 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.39253787 |
| 43 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.35716381 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32504637 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.31686478 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.31387398 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.29624725 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28525853 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28491228 |
| 50 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.27247098 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24650198 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 1.24353591 |
| 53 | Glioma_Homo sapiens_hsa05214 | 1.24003791 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.23688819 |
| 55 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.22575785 |
| 56 | Focal adhesion_Homo sapiens_hsa04510 | 1.19389768 |
| 57 | Long-term depression_Homo sapiens_hsa04730 | 1.18191024 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 1.15419323 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.15371884 |
| 60 | Insulin secretion_Homo sapiens_hsa04911 | 1.14565292 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.12379243 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 1.09843819 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 1.09558154 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.09300989 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08491160 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.08252650 |
| 67 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.08087246 |
| 68 | Gap junction_Homo sapiens_hsa04540 | 1.07411103 |
| 69 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.05913606 |
| 70 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.04455859 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 1.04073901 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03632327 |
| 73 | Axon guidance_Homo sapiens_hsa04360 | 1.03494599 |
| 74 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03075736 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02318459 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99580488 |
| 77 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99509764 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95793058 |
| 79 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95296562 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95063207 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94278910 |
| 82 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.94212695 |
| 83 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93446473 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92961155 |
| 85 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.92922510 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91856819 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.90263554 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89841451 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87198616 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.87176273 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.86268382 |
| 92 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.85963957 |
| 93 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85734578 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84073230 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.82578448 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.80548234 |
| 97 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.80282771 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.80222526 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.79550236 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.78068818 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77263702 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77256191 |
| 103 | Taste transduction_Homo sapiens_hsa04742 | 0.76697922 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76280294 |
| 105 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76258951 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76112562 |
| 107 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.75216490 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.74968521 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73709750 |
| 110 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72096541 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.69964639 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.69657072 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.67099606 |
| 114 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.67009973 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65861032 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.63805052 |
| 117 | Phototransduction_Homo sapiens_hsa04744 | 0.63688516 |
| 118 | Malaria_Homo sapiens_hsa05144 | 0.63652014 |
| 119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63068543 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62273626 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61586204 |
| 122 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.60347167 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59549458 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.59381691 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58489953 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.55557898 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.55409880 |
| 128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55399886 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.54833874 |
| 130 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54602174 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54083008 |
| 132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53068385 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52202313 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.52183748 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50764220 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50387972 |
| 137 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49600347 |
| 138 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.49405244 |
| 139 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49397663 |
| 140 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49287523 |
| 141 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48435901 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47742477 |
| 143 | Melanoma_Homo sapiens_hsa05218 | 0.46248995 |
| 144 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.46106795 |
| 145 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45615996 |
| 146 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44423895 |
| 147 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44278469 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.44248437 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.41465826 |
| 150 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.38746571 |
| 151 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35473737 |
| 152 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34010034 |
| 153 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28445427 |
| 154 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26837088 |

